Today's News | Note: News feeds may no longer be available for the articles on this page.

Teva says Parkinson's drug patent extended to 2017 11:55 AM 5/6/2009
Forbes - NY,USA
Teva Pharmaceutical Industries said that one of the patents on its Parkinson's disease drug Azilect has been extended by five years into 2017. ...

Acorda MS drug gets priority review status; shares rise 7:10 AM 5/6/2009
Reuters - USA
Acorda Therapeutics Inc said the US FDA assigned priority review status to its experimental multiple sclerosis drug Fampridine-SR and set October 22 as the target date to complete its review. ...

More Americans taking drugs for mental illness 7:59 AM 5/5/2009
Reuters - USA
More adults and children are using drugs to treat mental illness compared to 1996. The number over age 65 using psychotropic drugs (antidepressants, antipsychotics, and Alzheimer's meds) doubled in 10 years. ...

FDA grants orphan drug designation to Hyperion 6:56 AM 5/5/2009
Bizjournals.com - Charlotte,NC,USA
Hyperion Therapeutics' HPN-100 received orphan product designation from the US FDA as a maintenance treatment of patients with urea cycle disorders. The company is about to begin Phase III clinical trials. ...

Takeda, Lilly, Lead $28.5 Billion in Biotech Deals, Report Says 3:52 AM 5/5/2009
Bloomberg - USA
Biotechnology acquisitions in the US totaled $28.5 billion in 2008. Takeda Pharmaceutical and Eli Lilly bolstered product offerings the most. European biotech deals added up to $5 billion more led by Novartis AG’s acquisition of Speedel Holding AG. ...

Acadia in pact with Biovail for Parkinson's drug 7:50 AM 5/4/2009
Reuters - USA
Acadia Pharmaceuticals Inc and a Biovail Corp unit to co-develop and commercialize pimavanserin to treat Parkinson's disease psychosis (PDP) in the US and Canada. ...

Pharmaxis' cystic-fibrosis drug meets goal in study 5:48 AM 5/4/2009
Reuters - USA
Pharmaxis Ltd's experimental cystic-fibrosis drug Bronchitol met the main goal of improving lung function in a late-stage trial. ...

Roche deploys rapid response stockpile of Tamiflu 5:56 AM 5/3/2009
Reuters - USA
The World Health Organization asked Roche Holding AG to deploy its rapid response stockpiles of antiviral drug Tamiflu (oseltamivir). It's about 5 million treatment courses held by WHO and Roche. ...

Drug combo helps with repeat cancers in women 5:36 AM 5/2/2009
Reuters - USA
New research shows that topotecan and docetaxel combination treatment is effective for women who have had their uterine or ovarian cancer return and have already been treated with other drug combos. ...

US FDA says Solvay enzyme drug safe, effective 3:02 PM 5/1/2009
Reuters - USA
The US FDA approved Solvay SA's enzyme drug Creon (pancrelipase) for digestive disorder resulting from conditions such as cystic fibrosis and chronic pancreatitis. Creon treats exocrine pancreatic insufficiency where patients lack enzymes from the pancreas that are essential to food digestion. ...

Deaths of Polo Horses Highlight Practices of Disputed Pharmacies 11:32 AM 5/1/2009
New York Times - United States
Before the polo deaths federal regulators and veterinary groups warned that the drugs made by compounding pharmacies could be unreliable and unsafe. ...

FDA: 'Immediately Stop' Taking Hydroxycut Pdts 11:02 AM 5/1/2009
Wall Street Journal - USA
Consumers should immediately stop using Hydroxycut weight-loss products. They may cause jaundice and liver failure. The US FDA has 23 serious reports of health problems with Hydroxycut products and one death. ...

Amag shares jump om anemia drug approval hopes 10:10 AM 5/1/2009
Forbes - NY,USA
Shares of Amag Pharmaceuticals Inc rose a day after the drugmaker said it adequately addressed all issues raised by the US FDA on its anemia drug. ...

Botox must carry strong warning on risks-US FDA 10:59 AM 4/30/2009
Reuters - USA
Allergan Inc's wrinkle-filler Botox and a similar product must carry a strong warning about the risks of severe complications if the injected botulinum toxin spreads in the body. ...

Bayer, Regeneron aim to broaden use of eye drug 4:03 AM 4/30/2009
Reuters - USA
Bayer and Regeneron Pharmaceuticals plan to broaden the potential use of their experimental drug VEGF Trap-Eye planning a Phase III trial on Central Retinal Vein Occlusion (CRVO). ...

<- Day Earlier | Today's News